Based on the book of securities No. Authority (10/75) in 18.01.2016.
trading will launch on the shares of the Canadian company for the production of vaccines and veterinary medicines in 19/01/2016 to meet the company’s requirements for financial disclosure and resurrection provide the financial statements for the fiscal year ended 2014 and quarterly data for the third quarter 2015.
trading will launch on the shares of the Canadian company for the production of vaccines and veterinary medicines in 19/01/2016 to meet the company’s requirements for financial disclosure and resurrection provide the financial statements for the fiscal year ended 2014 and quarterly data for the third quarter 2015.